Skip to main content
Log in

Zinc balance and medications commonly used in the management of heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Heart failure (HF) is a prevalent syndrome resulting in a high mortality rate. HF may be associated with zinc deficiency through a reduction in dietary intake, decreased absorption due to gastrointestinal edema, impaired motility or intestinal zinc losses. Diseases concomitant with HF such as diabetes mellitus (DM) and hypertension may enhance zinc deficiency. Medications given for HF may affect zinc metabolism in different ways. It was shown that thiazides may cause zincuria and a decrease in tissue zinc concentration. There is conflicting evidence about furosemide, even though patients with chronic furosemide treatment showed low tissue zinc levels in autopsies. Treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) resulted in zincuria and zinc deficiency, but this outcome was not consistent in all studies. Beta-blockers did not alter plasma zinc concentration. Matrix metalloproteinases (MMPs) and ACE are zinc-containing enzymes, which play a role in the process of remodeling in HF. It was shown that ACE inhibitors may inhibit the activity of different MMPs. The exact interrelationship between HF, zinc-containing enzymes, zinc deficiency and the clinical manifestation of HF has to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weigand E. Absorption of trace elements: Zinc. Int J Vitam Nutr Res Suppl 1983;25:67–81.

    PubMed  CAS  Google Scholar 

  2. Sandstrom B. Bioavailability of zinc. Eur J Clin Nutr 1997; Suppl 1:S17–S19.

  3. King JC, Cousins RJ. Zinc. In: Shils ME, Shike M, Ross CA, Caballero B, Cousins RJ, editors Modern Nutrition in Health and Disease, 10th edn. Philadelphia: Lippincott Williams & Wilkins 2005. p. 271–85.

    Google Scholar 

  4. King JC. Assessment of techniques for determining human zinc requirements. J Am Diet Assoc 1986;86:1523–8.

    PubMed  CAS  Google Scholar 

  5. Walsh CT, Sandstead HH, Prasad AS, Newberne PM, Fraker PJ. Zinc: Health effects and research priorities for the 1990s. Environ Health Perspect 1994;102 Suppl 2:5–46.

    Google Scholar 

  6. Cousins RJ. Zinc. In: Ziegler E, Filer LJ, editors. Present Knowledge in Nutrition. Washington, DC: ILSI Press, 1996:293–306.

    Google Scholar 

  7. Prasad AS. Zinc deficiency. BMJ 2003;326:409–10.

    Article  PubMed  Google Scholar 

  8. Atlihan F, Soylemezoglu T, Gokce A, Guvendik G, Satici O. Zinc and copper in congestive heart failure. Turk J Pediatr 1990;32:33–8.

    PubMed  CAS  Google Scholar 

  9. Oster O. Trace element concentrations (Cu, Zn, Fe) in sera from patients with dilated cardiomyopathy. Clin Chim Acta 1993;214: 209–18.

    Article  PubMed  CAS  Google Scholar 

  10. Topuzoglu G, Erbay AR, Karul AB, Yensel N. Concentrations of copper, zinc, and magnesium in sera from patients with idiopathic dilated cardiomyopathy. Biol Trace Elem Res 2003;95:11–17.

    Article  PubMed  CAS  Google Scholar 

  11. Havranek E, Bumbalova A, Riecanska E, Riecansky I, Schreinerova Z, Belakova M, et al. Blood levels of Fe, Zn, Br and Rb determined by radionuclide x-ray fluorescence analysis in patients with dilated cardiomyopathy. Bratisl Lek Listy 1994;95:15–20.

    PubMed  CAS  Google Scholar 

  12. Chou HT, Yang HL, Tsou SS, Ho RK, Pai PY, Hsu HB. Status of trace elements in patients with idiopathic dilated cardiomyopathy in central Taiwan. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61: 193–8.

    CAS  Google Scholar 

  13. Golik A, Cohen N, Ramot Y, Maor J, Moses R, Weissgarten J, et al. Type II diabetes mellitus, congestive heart failure, and zinc metabolism. Biol Trace Elem Res 1993;39:171–5.

    PubMed  CAS  Google Scholar 

  14. Gorelik O, Almoznino-Sarafian D, Feder I, Wachsman O, Alon I, Litvinjuk V, et al. Dietary intake of various nutrients in older patients with congestive heart failure. Cardiology 2003;99: 177–81.

    Article  PubMed  CAS  Google Scholar 

  15. Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J 2005;26:2238–44.

    Article  PubMed  CAS  Google Scholar 

  16. Reyes AJ, Olhaberry JV, Leary WP, Lockett CJ, van der Byl K. Urianry zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. S Afr Med J 1983;64:936–41.

    PubMed  CAS  Google Scholar 

  17. Reyes AJ, Leary WP, Lockett CJ, Alcocer L. Diuretics and zinc. S Afr Med J 1982;62:373–5.

    PubMed  CAS  Google Scholar 

  18. Leary WP, Reyes AJ, Wynne RD, K van der Byl. Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects. J Int Med Res 1990;18: 120–41.

    PubMed  CAS  Google Scholar 

  19. Leary WP, Reyes AJ, van der Byl K. Effects of an acebutolol-hydrochlorothiazide combination on urinary solute excretion in healthy adults. S Afr Med J 1986;69:98–100.

    PubMed  CAS  Google Scholar 

  20. Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand 1980;208:209–12.

    Article  PubMed  CAS  Google Scholar 

  21. Golik A, Averbukh Z, Cohn M, Maor J, Berman S, Shaked U, et al. Effect of diuretics on captopril-induced urinary zinc excretion. Eur J Clin Pharmacol 1990;38:359–161.

    Article  PubMed  CAS  Google Scholar 

  22. Kirchgessner M, Motz C, Roth HP. Influence of dietary amiloride supplement on the zinc status of growing rats with marginal zinc supply. Res Exp Med (Berl) 1995;195:237–42.

    CAS  Google Scholar 

  23. Verho M, Bossaller W, Heinen B. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride. Int J Clin Pharmacol Res 1987;7:5–11.

    PubMed  CAS  Google Scholar 

  24. Golik A, Modai D, Weissgarten J, Cohen N, Averbukh Z, Sigler E, et al. Hydrochlorothiazide-amiloride causes excessive urinary zinc excretion. Clin Pharmacol Ther 1987;42:42–4.

    Article  PubMed  CAS  Google Scholar 

  25. Wester PO. Tissue zinc at autopsy-relation to medication with diuretics. Acta Med Scand 1980;208:269–71.

    Article  PubMed  CAS  Google Scholar 

  26. Mountokalakis T, Dourakis S, Karatzas N, Maravelias C, Koutselinis A. Zinc deficiency in mild hypertensive patients treated with diuretics. J Hypertens Suppl 2:S571–2.

  27. Berne X, Carias D, Cioccia AM, Gonzalez E, Hevia P. Effect of the diuretic furosemide on urinary essential nutrient loss and on body stores in growing rats. Arch Latinoam Nutr 2005;55: 154–60.

    PubMed  CAS  Google Scholar 

  28. Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, et al. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure. Miner Electrolyte Metab 1996;22:248–52.

    PubMed  CAS  Google Scholar 

  29. Cohen N, Alon I, Almoznino-Sarafian D, Zaidenstein R, Weissgarten J, Gorelik O, et al. Metabolic and clinical effect of oral magnesium supplementation in furosemide-treated patients with severe congestive heart failure. Clin Cardiol 2000;23:433–6.

    PubMed  CAS  Google Scholar 

  30. Allain P, Leblondel G, Granry JC. The effects of captopril and enalapril on tissue levels of various elements in spontaneously hypertensive rats. Fundam Clin Pharmacol 1989;3:329–35.

    Article  PubMed  CAS  Google Scholar 

  31. Zumkley H, Bertram HP, Vetter H, Zidek W, Losse H. Zinc metabolism during captopril treatment. Horm Metab Res 1985;17:256–8.

    Article  PubMed  CAS  Google Scholar 

  32. Abu-Hamdan DK, Desai H, Sondheimer J, Felicetta J, Mahajan S, McDonald F. Taste acuity and zinc metabolism in captopril-treated hypertensive male patients. Am J Hypertens 1988;1:303S–8S.

    PubMed  CAS  Google Scholar 

  33. O’Connor DT, Strause L, Saltman P, Parmer RJ, Cervenka J. Serum zinc is unaffected by effective captopril treatment of hypertension. J Clin Hypertens 1987;3:405–8.

    PubMed  CAS  Google Scholar 

  34. Golik A, Modai D, Averbukh Z, Sheffy M, Shamis A, Cohen N, et al. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665–7.

    Article  PubMed  CAS  Google Scholar 

  35. Rubio-Luengo MA, Maldonado-Martin A, Gil-Extremera B, Gonzalez-Gomez L, Luna del Castillo JD. Variations in magnesium and zinc in hypertensive patients receiving different treatments. Am J Hypertens 1995;8:689–95.

    Article  PubMed  CAS  Google Scholar 

  36. Golik A, Zaidenstein R, Dishi V, Blatt A, Cohen N, Cotter G, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998;17:75–8.

    PubMed  CAS  Google Scholar 

  37. Baykal Y, Yilmaz MI, Celik T, Gok F, Rehber H, Akay C, et al. Effects of antihypertensive agents, alpha receptor blockers, beta blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers, on oxidative stress. J Hypertens 2003;21:1207–11.

    Article  PubMed  CAS  Google Scholar 

  38. Koren-Michowitz M, Dishy V, Zaidenstein R, Yona O, Berman S, Weissgarten J, et al. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study. Am J Hypertens 2005;18:358–63.

    Article  PubMed  CAS  Google Scholar 

  39. Reinhardt D, Sigusch HH, Hensse J, Tyagi SC, Korfer R, Figulla HR. Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart 2002;88:525–30.

    Article  PubMed  CAS  Google Scholar 

  40. Zumkley H, Bertram HP, Vetter H, Zidek W, Wessels F. Zinc concentrations in plasma and erythrocytes in digitalized patients. Klin Wochenschr 1981;59:1345–7.

    Article  PubMed  CAS  Google Scholar 

  41. Wester PO. The urinary excretion of trace elements before and during treatment with hydralazine. Acta Med Scand 1975;197: 307–9.

    Article  PubMed  CAS  Google Scholar 

  42. Peters JM, Lonnerdal B, Keen CL. Effect of the antihypertensive drug hydralazine on mineral metabolism in the rat. Toxicol Lett 1988;41:193–202.

    Article  PubMed  CAS  Google Scholar 

  43. Ghayour-Mobarhan M, Lamb DJ, Taylor A, Vaidya N, Livingstone C, Wang T, et al. Effect of statin therapy on serum trace element status in dyslipidaemic subjects. J Trace Elem Med Biol 2005;19:61–7.

    Article  PubMed  CAS  Google Scholar 

  44. Leonhardt W, Kurktschiev T, Meissner D, Lattke P, Abletshauser C, Weidinger G, et al. Effects of fluvastatin therapy on lipids, antioxidants, oxidation of low density lipoproteins and trace metals. Eur J Clin Pharmacol 1997;53:65–9.

    Article  PubMed  CAS  Google Scholar 

  45. Hidalgo J, Giralt M, Garvey JS, Armario A. Effect of morphine administration on rat liver metallothionein and zinc metabolism. J Pharmacol Exp Ther 1991;259:274–8.

    PubMed  CAS  Google Scholar 

  46. Lo HS, Chiang HC, Lin AM, Chiang HY, Chu YC, Kao LS. Synergistic effects of dopamine and Zn2+ on the induction of PC12 cell death and dopamine depletion in the striatum: possible implication in the pathogenesis of Parkinson’s disease. Neurobiol Dis 2004;17:54–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahuva Golik.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohen, N., Golik, A. Zinc balance and medications commonly used in the management of heart failure. Heart Fail Rev 11, 19–24 (2006). https://doi.org/10.1007/s10741-006-9189-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-006-9189-1

Keywords

Navigation